A meta-analysis found that patients with early and intermediate-stage hepatocellular carcinoma who received external beam radiation therapy (EBRT) demonstrated better local control and progression-free survival than those who received transarterial chemoembolization (TACE). The findings suggest that EBRT can be used as an effective frontline treatment for patients with hepatocellular carcinoma.
